Business Description
Anuh Pharma Ltd
ISIN : INE489G01022
Compare
Compare
Traded in other countries / regions
506260.India IPO Date
1993-08-18Description
Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.7 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.17 | |||||
| Interest Coverage | 115.89 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 7.13 | |||||
| Beneish M-Score | -1.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.4 | |||||
| 3-Year EBITDA Growth Rate | 16.5 | |||||
| 3-Year EPS without NRI Growth Rate | 31.6 | |||||
| 3-Year Book Growth Rate | 15.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.61 | |||||
| 9-Day RSI | 65.82 | |||||
| 14-Day RSI | 60.08 | |||||
| 6-1 Month Momentum % | -17.72 | |||||
| 12-1 Month Momentum % | 21.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.43 | |||||
| Quick Ratio | 1.88 | |||||
| Cash Ratio | 0.4 | |||||
| Days Inventory | 56.98 | |||||
| Days Sales Outstanding | 99.67 | |||||
| Days Payable | 92.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.2 | |||||
| Dividend Payout Ratio | 0.25 | |||||
| Forward Dividend Yield % | 1.2 | |||||
| 5-Year Yield-on-Cost % | 1.22 | |||||
| Shareholder Yield % | 0.89 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.47 | |||||
| Operating Margin % | 9.93 | |||||
| Net Margin % | 9.22 | |||||
| FCF Margin % | 1.24 | |||||
| ROE % | 20.81 | |||||
| ROA % | 13.84 | |||||
| ROIC % | 20.21 | |||||
| ROC (Joel Greenblatt) % | 43.89 | |||||
| ROCE % | 26.63 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.67 | |||||
| PE Ratio without NRI | 20.52 | |||||
| Shiller PE Ratio | 26.54 | |||||
| Price-to-Owner-Earnings | 66.2 | |||||
| PEG Ratio | 0.95 | |||||
| PS Ratio | 1.63 | |||||
| PB Ratio | 3.44 | |||||
| Price-to-Tangible-Book | 3.44 | |||||
| Price-to-Free-Cash-Flow | 131.85 | |||||
| Price-to-Operating-Cash-Flow | 80.67 | |||||
| EV-to-EBIT | 13.2 | |||||
| EV-to-EBITDA | 11.93 | |||||
| EV-to-Revenue | 1.57 | |||||
| EV-to-FCF | 121.27 | |||||
| Price-to-Projected-FCF | 3.09 | |||||
| Price-to-Median-PS-Value | 1.08 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.98 | |||||
| Price-to-Graham-Number | 1.77 | |||||
| Price-to-Net-Current-Asset-Value | 5.69 | |||||
| Earnings Yield (Greenblatt) % | 7.56 | |||||
| FCF Yield % | 0.76 | |||||
| Forward Rate of Return (Yacktman) % | 20.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anuh Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,398.541 | ||
| EPS (TTM) (₹) | 11.77 | ||
| Beta | 0.61 | ||
| Volatility % | 45.4 | ||
| 14-Day RSI | 60.08 | ||
| 14-Day ATR (₹) | 7.958066 | ||
| 20-Day SMA (₹) | 196.345 | ||
| 12-1 Month Momentum % | 21.13 | ||
| 52-Week Range (₹) | 140.1 - 265 | ||
| Shares Outstanding (Mil) | 50.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anuh Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anuh Pharma Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anuh Pharma Ltd Frequently Asked Questions
What is Anuh Pharma Ltd(BOM:506260)'s stock price today?
The current price of BOM:506260 is ₹208.05. The 52 week high of BOM:506260 is ₹265.00 and 52 week low is ₹140.10.
When is next earnings date of Anuh Pharma Ltd(BOM:506260)?
The next earnings date of Anuh Pharma Ltd(BOM:506260) is .
Does Anuh Pharma Ltd(BOM:506260) pay dividends? If so, how much?
The Dividend Yield %  of Anuh Pharma Ltd(BOM:506260) is 1.2% (As of Today), Highest Dividend Payout Ratio of Anuh Pharma Ltd(BOM:506260) was 0.85. The lowest was 0.07. And the median was 0.31. The  Forward Dividend Yield % of Anuh Pharma Ltd(BOM:506260) is 1.2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers